These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7919804)

  • 1. Sequential study of an experimental model of graft vs. host disease (GvHD) in non-immunosuppressed F1 (CBA/J x C57BL/6) mice.
    Acosta A; Infante JF; Sarmiento ME; Izquierdo L; Capó V; Dueñas P; Zamanillo T; Sierra G
    Arch Med Res; 1994; 25(2):155-7. PubMed ID: 7919804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental model of graft vs. host disease in non-immunosuppressed F1 (CBA/J x C57BL/6) mice.
    Acosta A; Sarmiento ME; Infante JF; Sierra G; Izquierdo L; Capó V; Zamanillo T
    Arch Med Res; 1994; 25(2):151-4. PubMed ID: 7919803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of a glucocorticoid-sensitive F1-anti-parental mechanism that affects engraftment during graft-versus-host disease.
    You-Ten KE; Seemayer TA; Wisse B; Bertley FM; Lapp WS
    J Immunol; 1995 Jul; 155(1):172-80. PubMed ID: 7602093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lethal systemic graft-vs-host disease in neonatally tolerant, but not in F1 hybrid mice.
    Vizler C; Jánossy T; Baranyi L; Végh P
    Cell Immunol; 1993 Feb; 146(2):431-7. PubMed ID: 8174181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.
    Ellison CA; Fischer JM; HayGlass KT; Gartner JG
    J Immunol; 1998 Jul; 161(2):631-40. PubMed ID: 9670937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical GvHD in non-irradiated F1 hybrids: severe lymphoid-tissue GvHD causing prolonged immune dysfunction.
    Sprangers B; Van Wijmeersch B; Luyckx A; Sagaert X; Verbinnen B; Rutgeerts O; Lenaerts C; Tousseyn T; Dubois B; Waer M; Billiau AD
    Bone Marrow Transplant; 2011 Apr; 46(4):586-96. PubMed ID: 20603621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel IMPDH inhibitor VX-497 prolongs skin graft survival and improves graft versus host disease in mice.
    Decker CJ; Heiser AD; Chaturvedi PR; Faust TJ; Ku G; Moseley S; Nimmesgern E
    Drugs Exp Clin Res; 2001; 27(3):89-95. PubMed ID: 11447770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model.
    Nagler A; Ohana M; Alper R; Doviner V; Sherman Y; Rabbani E; Engelhardt D; Ilan Y
    Bone Marrow Transplant; 2003 Aug; 32(4):363-9. PubMed ID: 12900772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes.
    Margalit M; Ilan Y; Ohana M; Safadi R; Alper R; Sherman Y; Doviner V; Rabbani E; Engelhardt D; Nagler A
    Bone Marrow Transplant; 2005 Jan; 35(2):191-7. PubMed ID: 15558045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both apoptosis and complement membrane attack complex deposition are major features of murine acute graft-vs.-host disease.
    Niculescu F; Niculescu T; Nguyen P; Puliaev R; Papadimitriou JC; Gaspari A; Rus H; Via CS
    Exp Mol Pathol; 2005 Oct; 79(2):136-45. PubMed ID: 15979610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of burn injury on the reactivity of spleen cells of mice of different genotypes during regional graft vs host reaction].
    Barsukov AN; Fedorov GN; Semenkov VF
    Biull Eksp Biol Med; 1990 Jun; 109(6):592-4. PubMed ID: 2397303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
    Cohen P; Vourka-Karussis U; Weiss L; Slavin S
    J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
    Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T
    Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the immunosuppressive effects of nitric oxide in graft vs host disease.
    Hoffman RA; Langrehr JM; Wren SM; Dull KE; Ildstad ST; McCarthy SA; Simmons RL
    J Immunol; 1993 Aug; 151(3):1508-18. PubMed ID: 8335943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity.
    Ilan Y; Ohana M; Pappo O; Margalit M; Lalazar G; Engelhardt D; Rabbani E; Nagler A
    Transplantation; 2007 Feb; 83(4):458-67. PubMed ID: 17318079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease.
    Via CS; Rus V; Gately MK; Finkelman FD
    J Immunol; 1994 Nov; 153(9):4040-7. PubMed ID: 7930611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.